The company recently received 510(k) clearance from the Food and Drug Administration to market lateral access implants and plans to introduce these products later this year.
More Articles on Devices:
7 Recent Orthopedic Device Company Expansions & Agreements
U.S. Spine Market Worth $5.5B, $1.5B From Minimally Invasive Devices
Lanx Launches TIMBERLINE Lateral Interbody Spine Fusion Device
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
